\-\ Texto\\:\\ \ \(0\)\
\-\ heent\\:\\ perrla\\,\\ eomi\ \(0\)\
\-\ motor\\:\\ strength\\ on\\ right\\ 0\\/5\\ strength\\ in\\ both\\ upper\\ and\\ lower\\ extremities\\.\\ strength\\ on\\ left\\ \\ 5\\/5\\ in\\ upper\\ and\\ lower\\ extremities\ \(0\)\
\-\ speech\\:\\ patient\\ is\\ aphasic\ \(0\)\
\-\ neurosurgery\\ contacted\\ to\\ monitor\\ increasing\\ brain\\ edema\\.\\ standard\\ stroke\\ workup\\-\\ tcd\\,\\ tte\\ with\\ bubble\\ study\\,\\ pt\\/ot\\,\\ patient\\ started\\ on\\ asa\\ 325mg\\ qd\\,\\ and\\ lipitor\\ 20mg\\ qhs\ \(0\)\
\-\ on\\ ct\\-\\ there\\ is\\ early\\ evidence\\ of\\ ischemic\\ infarction\\ in\\ the\\ left\\ hemisphere\\ along\\ with\\ a\\ hyperdense\\ mca\\ sign\\ in\\ the\\ left\\ mca\\.\ \(0\)\
\-\ mri\\ demonstrates\\ a\\ massive\\ left\\ cerebral\\ infarction\\,\\ including\\ \\ infarction\\ of\\ the\\ left\\ frontal\\,\\ temporal\\,\\ parietal\\ and\\ occipital\\ lobes\\ with\\ involvement\\ of\\ the\\ basal\\ ganglia\\ but\\ sparing\\ of\\ the\\ thalamus\\ is\\ present\\.\\ no\\ right\\ sided\\ abnormality\\.\ \(0\)\
\-\ massive\\ left\\ hemisphere\\ stroke\ \(0\)\
\-\ 1\\)\\ stroke\\:\\ ischemic\\ vs\\ hemorrhagic\ \(0\)\
\-\ 2\\)\\ abcess\\/infection\ \(0\)\
\-\ 3\\)\\ tumor\ \(0\)\
\-\ 61y\\/o\\ male\\ with\\ no\\ prior\\ past\\ medical\\ history\\ who\\ presented\\ with\\ right\\ sided\\ weakness\\ and\\ difficulty\\ speaking\\ for\\ unknown\\ duration\ \(1\)\
\-\ this\\ patient\\ suffered\\ a\\ massive\\ cerebrovascular\\ accident\\,\\ that\\ caused\\ ischemia\\ to\\ most\\ of\\ cortex\\ in\\ the\\ left\\ hemisphere\\.\\ due\\ to\\ the\\ massive\\ nature\\ of\\ the\\ patient\\'s\\ stroke\\,\\ there\\ was\\ significant\\ concern\\ about\\ cerebral\\ edema\\ and\\ possible\\ herniation\\,\\ which\\ is\\ why\\ neurosurgery\\ was\\ contacted\\ to\\ help\\ monitor\\ the\\ patient\\ and\\ perform\\ a\\ hemicraniectomy\\ if\\ warranted\\ to\\ prevent\\ brain\\ herniation\ \(0\)\
\-\ in\\ addition\\,\\ the\\ initial\\ non\\-contrast\\ head\\ ct\\,\\ showed\\ an\\ early\\ sign\\ of\\ ischemia\\ known\\ as\\ the\\ hyperdense\\ mca\\ sign\\,\\ caused\\ by\\ an\\ acute\\ thrombus\\ in\\ the\\ vasculature\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ massive\\:\\ 0\\.2816817272580478\ \(0\)\
\-\ stroke\\:\\ 0\\.25480209410616284\ \(0\)\
\-\ mca\\:\\ 0\\.2126741912252179\ \(0\)\
\-\ hemisphere\\:\\ 0\\.19230919956859333\ \(0\)\
\-\ contacted\\:\\ 0\\.1857943450467251\ \(0\)\
\-\ strength\\:\\ 0\\.17214947470467956\ \(0\)\
\-\ the\\:\\ 0\\.16401502159554737\ \(0\)\
\-\ left\\:\\ 0\\.1635641549393184\ \(0\)\
\-\ infarction\\:\\ 0\\.1613211159434588\ \(0\)\
\-\ sign\\:\\ 0\\.14226682361798332\ \(0\)\
\-\ monitor\\:\\ 0\\.13993448625987095\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.13863599977627078\ \(0\)\
\-\ hyperdense\\:\\ 0\\.12611645478437192\ \(0\)\
\-\ ischemic\\:\\ 0\\.12116104810677282\ \(0\)\
\-\ in\\:\\ 0\\.1192813013586342\ \(0\)\
\-\ ischemia\\:\\ 0\\.1186510554812185\ \(0\)\
\-\ herniation\\:\\ 0\\.11523878055476788\ \(0\)\
\-\ patient\\:\\ 0\\.11139550015615868\ \(0\)\
\-\ caused\\:\\ 0\\.10984794318390277\ \(0\)\
\-\ aphasic\\:\\ 0\\.10467504364225015\ \(0\)\
\-\ tcd\\:\\ 0\\.10467504364225015\ \(0\)\
\-\ qhs\\:\\ 0\\.10467504364225015\ \(0\)\
\-\ extremities\\:\\ 0\\.104110679336082\ \(0\)\
\-\ 325mg\\:\\ 0\\.10122053577337538\ \(0\)\
\-\ and\\:\\ 0\\.09908053111356142\ \(0\)\
\-\ early\\:\\ 0\\.09875163038781773\ \(0\)\
\-\ hemicraniectomy\\:\\ 0\\.09854101129924328\ \(0\)\
\-\ lipitor\\:\\ 0\\.09635168039223731\ \(0\)\
\-\ 20mg\\:\\ 0\\.09635168039223731\ \(0\)\
\-\ cerebral\\:\\ 0\\.0949126800456775\ \(0\)\
\-\ of\\:\\ 0\\.09383387462635756\ \(0\)\
\-\ asa\\:\\ 0\\.09289717252336255\ \(0\)\
\-\ tte\\:\\ 0\\.09148282501109922\ \(0\)\
\-\ speaking\\:\\ 0\\.09148282501109922\ \(0\)\
\-\ cerebrovascular\\:\\ 0\\.09021764804923044\ \(0\)\
\-\ sided\\:\\ 0\\.088123360567363\ \(0\)\
\-\ to\\:\\ 0\\.08562236263343333\ \(0\)\
\-\ brain\\:\\ 0\\.08540347861692917\ \(0\)\
\-\ why\\:\\ 0\\.08315946176108638\ \(0\)\
\-\ on\\:\\ 0\\.0827508044285887\ \(0\)\
\-\ edema\\:\\ 0\\.08170793369656101\ \(0\)\
\-\ qd\\:\\ 0\\.07921476032508548\ \(0\)\
\-\ thalamus\\:\\ 0\\.07921476032508548\ \(0\)\
\-\ perrla\\:\\ 0\\.07785390098537846\ \(0\)\
\-\ warranted\\:\\ 0\\.07663168677017776\ \(0\)\
\-\ bubble\\:\\ 0\\.07588093764175204\ \(0\)\
\-\ suffered\\:\\ 0\\.07552246102473209\ \(0\)\
\-\ is\\:\\ 0\\.07503503988903738\ \(0\)\
\-\ eomi\\:\\ 0\\.07450708957726937\ \(0\)\
\-\ upper\\:\\ 0\\.07320899851477441\ \(0\)\
\-\ sparing\\:\\ 0\\.0718926496791871\ \(0\)\
\-\ speech\\:\\ 0\\.070653605643594\ \(0\)\
\-\ perform\\:\\ 0\\.070653605643594\ \(0\)\
\-\ lower\\:\\ 0\\.07000554340617135\ \(0\)\
\-\ right\\:\\ 0\\.06813018949643244\ \(0\)\
\-\ vasculature\\:\\ 0\\.0673769984342447\ \(0\)\
\-\ with\\:\\ 0\\.0670642431029196\ \(0\)\
\-\ duration\\:\\ 0\\.06602254169393455\ \(0\)\
\-\ ganglia\\:\\ 0\\.06437912637926085\ \(0\)\
\-\ thrombus\\:\\ 0\\.06370052352654071\ \(0\)\
\-\ standard\\:\\ 0\\.06356928642917425\ \(0\)\
\-\ help\\:\\ 0\\.06293379026945295\ \(0\)\
\-\ concern\\:\\ 0\\.06281062944739438\ \(0\)\
\-\ prevent\\:\\ 0\\.06281062944739438\ \(0\)\
\-\ heent\\:\\ 0\\.06120717448535279\ \(0\)\
\-\ nature\\:\\ 0\\.060479189486748006\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.059417544090367\ \(0\)\
\-\ occipital\\:\\ 0\\.05861372976968724\ \(0\)\
\-\ basal\\:\\ 0\\.05861372976968724\ \(0\)\
\-\ accident\\:\\ 0\\.05852765001122067\ \(0\)\
\-\ started\\:\\ 0\\.05769917844392171\ \(0\)\
\-\ difficulty\\:\\ 0\\.05761939027738394\ \(0\)\
\-\ lobes\\:\\ 0\\.05715148400929536\ \(0\)\
\-\ cortex\\:\\ 0\\.055779703272851595\ \(0\)\
\-\ addition\\:\\ 0\\.05544332063609277\ \(0\)\
\-\ parietal\\:\\ 0\\.05531136244130023\ \(0\)\
\-\ there\\:\\ 0\\.05451062408559627\ \(0\)\
\-\ motor\\:\\ 0\\.05448726619738154\ \(0\)\
\-\ increasing\\:\\ 0\\.05394815983397249\ \(0\)\
\-\ temporal\\:\\ 0\\.052618721554193525\ \(0\)\
\-\ an\\:\\ 0\\.05238713811178521\ \(0\)\
\-\ vs\\:\\ 0\\.05225716080337357\ \(0\)\
\-\ ct\\:\\ 0\\.052155989553910126\ \(0\)\
\-\ unknown\\:\\ 0\\.05190616911764647\ \(0\)\
\-\ about\\:\\ 0\\.051280356273298355\ \(0\)\
\-\ weakness\\:\\ 0\\.04999174891397759\ \(0\)\
\-\ abnormality\\:\\ 0\\.049824386276088775\ \(0\)\
\-\ involvement\\:\\ 0\\.049577636329241455\ \(0\)\
\-\ including\\:\\ 0\\.04902087088310187\ \(0\)\
\-\ was\\:\\ 0\\.04774476086647824\ \(0\)\
\-\ possible\\:\\ 0\\.046411500892160264\ \(0\)\
\-\ initial\\:\\ 0\\.04595136510013846\ \(0\)\
\-\ along\\:\\ 0\\.045891324600632326\ \(0\)\
\-\ study\\:\\ 0\\.04568351589355549\ \(0\)\
\-\ showed\\:\\ 0\\.045624796583959654\ \(0\)\
\-\ past\\:\\ 0\\.04458728168338583\ \(0\)\
\-\ no\\:\\ 0\\.04454981892478685\ \(0\)\
\-\ known\\:\\ 0\\.044347910138096865\ \(0\)\
\-\ frontal\\:\\ 0\\.04408742107571263\ \(0\)\
\-\ medical\\:\\ 0\\.043533491322412625\ \(0\)\
\-\ head\\:\\ 0\\.04085396684828051\ \(0\)\
\-\ presented\\:\\ 0\\.03994440351840664\ \(0\)\
\-\ if\\:\\ 0\\.03979928906495469\ \(0\)\
\-\ significant\\:\\ 0\\.03954948355054861\ \(0\)\
\-\ due\\:\\ 0\\.03937418007387838\ \(0\)\
\-\ evidence\\:\\ 0\\.03887981051127132\ \(0\)\
\-\ who\\:\\ 0\\.03874693972395927\ \(0\)\
\-\ prior\\:\\ 0\\.03832499097941955\ \(0\)\
\-\ both\\:\\ 0\\.038198088082250406\ \(0\)\
\-\ acute\\:\\ 0\\.03705503087672498\ \(0\)\
\-\ tumor\\:\\ 0\\.03582865225195095\ \(0\)\
\-\ most\\:\\ 0\\.03564865632464057\ \(0\)\
\-\ mri\\:\\ 0\\.03516101522322374\ \(0\)\
\-\ present\\:\\ 0\\.03514876833293799\ \(0\)\
\-\ demonstrates\\:\\ 0\\.034412865526539826\ \(0\)\
\-\ but\\:\\ 0\\.03387257983899603\ \(0\)\
\-\ which\\:\\ 0\\.03114691688113766\ \(0\)\
\-\ male\\:\\ 0\\.030498135301930986\ \(0\)\
\-\ that\\:\\ 0\\.029725749090043566\ \(0\)\
\-\ by\\:\\ 0\\.029088405392064233\ \(0\)\
\-\ as\\:\\ 0\\.027518249688446527\ \(0\)\
\-\ history\\:\\ 0\\.026170365039233923\ \(0\)\
\-\ this\\:\\ 0\\.02353729352393929\ \(0\)\
\-\ for\\:\\ 0\\.020761347918092306\ \(0\)\
